Groundbreaking, ultrasound-based
whole blood hemostasis testing
for critically bleeding patients
who need targeted therapy — fast.
Only one company listens to blood.
HemoSonics.
Proud to be your partner in better bleeding management
Groundbreaking, ultrasound-based whole blood hemostasis testing
for critically bleeding patients who need targeted therapy – fast.
Only one company listens to blood.
Laboratory
Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam labore excepturi eum velit dignissimos explicabo reprehenderit dolorum esse!
Products
Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam labore excepturi eum velit dignissimos explicabo reprehenderit dolorum esse!
Clinicians
Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam labore excepturi eum velit dignissimos explicabo reprehenderit dolorum esse!
Historically, viscoelastic testing has been demonstrated1-3 to reduce:
Unnecessary blood product usage
Length of stay in hospital
Complications associated with bleeding or transfusions
Costs associated with blood product usage
Time between diagnostics and hemostatic intervention
Watch Quantra in Action
Watch Quantra in Action
1. References
- Weber CF, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012 Sep;117(3):531-47.
- Pearse BL, et al. Protocol guided bleeding management improves cardiac surgery patient outcomes. Vox Sang. 2015 Oct;109(3):267-79.
- Haas T, et al. Reproducibility of thrombelastometry: Point-of-care versus hospital laboratory performance. Scand J Clin Lab Invest. 2012;72(4):313-17.